Kernel Capital through The Bank of Ireland Kernel Capital Growth Funds (NI) has led an £1.5m investment in Queens University Belfast (QUB) campus company, Causeway Sensors. The investment comprised of £1.3M from the Bank of Ireland Kernel Capital Growth Fund NI and £250k from existing investor QUBIS.

To make a new biological drug, pharmaceutical companies need to screen millions of candidates and to highly characterise potential leads. Current instrumentation can only capture this critical data after protracted incubation periods. This increases the lead time and risk in taking a drug to market.  To address this problem, Causeway are developing what may be the world’s first Nano Sensor Platform that can be integrated directly into a bioreactor unlocking key data in real-time. These inline sensors may reduce risk, improve decision making and enable new drugs to be brought to market faster.

Causeway Sensors was established in 2016 and its patented Nano Sensor Platform is the result of five years of high impact research and development following twenty years of pure research at Queens University Belfast. Earlier this year it was confirmed that Causeway Sensors Limited was awarded £3.3M in grant support from UK Research & Innovation as part of the Smart Nano NI consortium, led by Seagate Technology and also featuring another joint Kernel Capital / QUBIS portfolio company, Cirdan Imaging.

In co-ordination with the investment the board and executive team have been enhanced and restructured. This includes Dr Bob Pollard, Founder taking on the role of Executive President, Dr Antony Murphy is promoted to Chief Executive Officer and Deirdre Francis, formerly of Intelesens has been appointed to the newly created role of Finance Director.

There is an unmet need for instrumentation that can provide high value data in real time, online, throughout the drug development process, we believe Causeway Sensors can deliver on that need.”

Niall Olden, Managing Partner, Kernel Capital

“Causeway is a great example of the deep tech that exists within the current QUBIS portfolio and we are delighted to once again support the team with their plans to bring this ground breaking technology into the market.”

David Moore, Head of Spin-outs & Investments, QUBIS

“This latest round of funding is the final stepping-stone on the path to commercialisation of Causeway’s technology and I want to take the opportunity to thank our investors for their continued support on our journey. This investment, along with the competitive grant-funding we were awarded from UKRI, will put Causeway in a strong position to fully validate our first product with blue-chip pharmaceutical companies before entering the bioproduction market.”

Antony Murphy, CEO, Causeway Sensors.

The Bank of Ireland Kernel Capital Growth Fund (NI) was designed to help SMEs in Northern Ireland to accelerate their growth. Invest Northern Ireland has committed £15 million of funding to this fund which is part financed by the European Regional Development Fund under the EU Investment for Growth and Jobs Programme 2014-2020. Invest NI’s R&D support is part funded by ERDF under the EU Investment for Growth and Jobs Programme 2014-2020.

# # #

For further information please contact:

Dawn Walsh, Kernel Capital.

Tel:  +353 21 4928974

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published.